|
|
||||
|
Reverse vaccinology success story
The Scientist 2005, 19(15):26
|
||||
|
|
||||
|
In a finding that further validates an emerging vaccine strategy, researchers in Italy and the United States have worked backward from genome to antigens to identify a protein cocktail that may confer global protection against group B streptococcus (GBS).[1]
|
|
|||||||||
|
|||||||||
|